Literature DB >> 9148002

Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice.

K Reifenberg1, J Löhler, H P Pudollek, E Schmitteckert, G Spindler, J Köck, H J Schlicht.   

Abstract

BACKGROUND/AIMS: Chronic infections with the human hepatitis B virus can result in liver cirrhosis and primary hepatocellular carcinoma. The reasons for these long-term effects are unclear. The aim of this study was to generate transgenic mice expressing the HBV X- and c/e-gene under authentic and foreign promoter control and to test whether the respective gene products can cause pathologic effects during the lifespan of a mouse. Moreover, the temporal and the tissue-specific regulation of the crucial HBV c/e-gene promoter was analyzed.
METHODS: Eight transgenic mouse lines were generated. Four contained the c/e- and X-gene and two contained only the X-gene under authentic promoter control. Two lines expressed only the X-gene under control of the rat insulin promoter/enhancer. Gene expression was tested by protein and mRNA analyses. During an observation period of 2 years, mice were sacrificed and organs subjected to histologic examination. Mice expressing the X-gene in pancreatic beta cells were tested for the development of diabetes.
RESULTS: In the liver, slight histopathologic alterations but no neoplastic changes could be observed in mice expressing the X-gene. Activity of the c/e-gene promoter/enhancer was age dependent and was not restricted to hepatocytes.
CONCLUSION: No evidence was obtained that long-term expression of the HBV c/e- and X-gene products can cause neoplasia during the lifespan of a mouse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9148002     DOI: 10.1016/s0168-8278(97)80018-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

1.  Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes.

Authors:  Y P Hu; W J Hu; W C Zheng; J X Li; D S Dai; X M Wang; S Z Zhang; H Y Yu; W Sun; G R Hao
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  The hepatitis B virus X protein transactivates viral core gene expression in vivo.

Authors:  K Reifenberg; H Wilts; J Löhler; P Nusser; R Hanano; L G Guidotti; F V Chisari; H J Schlicht
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice.

Authors:  Min Lian; Ying Liu; Shun-Zhang Yu; Geng-Sun Qian; Shu-Guang Wan; Kenneth-R Dixon
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

6.  Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.

Authors:  S Lee; W Kim; C Ko; W-S Ryu
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

Review 7.  Mouse models in liver cancer research: a review of current literature.

Authors:  Martijn W H Leenders; Maarten W Nijkamp; Inne H M Borel Rinkes
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

Review 8.  Hepatitis B Virus X and Regulation of Viral Gene Expression.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-08       Impact factor: 6.915

Review 9.  MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects.

Authors:  Yi Lin Jane Tan; Wei Ning Chen
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 10.  Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis.

Authors:  Shogo Ohkoshi; Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Masahiko Yano
Journal:  World J Hepatol       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.